These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
787 related articles for article (PubMed ID: 18385765)
1. Immunity to adeno-associated virus vectors in animals and humans: a continued challenge. Zaiss AK; Muruve DA Gene Ther; 2008 Jun; 15(11):808-16. PubMed ID: 18385765 [TBL] [Abstract][Full Text] [Related]
2. Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands. Aldrich WA; Ren C; White AF; Zhou SZ; Kumar S; Jenkins CB; Shaw DR; Strong TV; Triozzi PL; Ponnazhagan S Gene Ther; 2006 Jan; 13(1):29-39. PubMed ID: 16136165 [TBL] [Abstract][Full Text] [Related]
10. Gene therapy progress and prospects--vectorology: design and production of expression cassettes in AAV vectors. Le Bec C; Douar AM Gene Ther; 2006 May; 13(10):805-13. PubMed ID: 16453010 [TBL] [Abstract][Full Text] [Related]
11. Immune responses to gene therapy vectors: influence on vector function and effector mechanisms. Bessis N; GarciaCozar FJ; Boissier MC Gene Ther; 2004 Oct; 11 Suppl 1():S10-7. PubMed ID: 15454952 [TBL] [Abstract][Full Text] [Related]
14. Production of adeno-associated viral vectors in insect cells using triple infection: optimization of baculovirus concentration ratios. Aucoin MG; Perrier M; Kamen AA Biotechnol Bioeng; 2006 Dec; 95(6):1081-92. PubMed ID: 16952153 [TBL] [Abstract][Full Text] [Related]
15. Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice. Rivière C; Danos O; Douar AM Gene Ther; 2006 Sep; 13(17):1300-8. PubMed ID: 16688207 [TBL] [Abstract][Full Text] [Related]
16. Manufacturing and characterizing AAV-based vectors for use in clinical studies. Wright JF Gene Ther; 2008 Jun; 15(11):840-8. PubMed ID: 18418418 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models. Davidoff AM; Gray JT; Ng CY; Zhang Y; Zhou J; Spence Y; Bakar Y; Nathwani AC Mol Ther; 2005 Jun; 11(6):875-88. PubMed ID: 15922958 [TBL] [Abstract][Full Text] [Related]
18. Tailoring the AAV vector capsid for gene therapy. Vandenberghe LH; Wilson JM; Gao G Gene Ther; 2009 Mar; 16(3):311-9. PubMed ID: 19052631 [TBL] [Abstract][Full Text] [Related]
19. Production and characterization of adeno-associated viral vectors. Grieger JC; Choi VW; Samulski RJ Nat Protoc; 2006; 1(3):1412-28. PubMed ID: 17406430 [TBL] [Abstract][Full Text] [Related]